Industry News
FDA Crackdown Ends the Shortage Loophole: What the New GLP-1 Compounding Rules Mean for Pharmacies
The FDA has closed the shortage loophole that fueled the compounded GLP-1 boom. With semaglutide and tirzepatide off the shortage list, compounding…
Apr 23, 2026 / 7 min read